Skip to main content
. 2019 Jan;20(1):74–87. doi: 10.1016/S1470-2045(18)30646-6

Table 3.

Proportion of patients diagnosed with colorectal adenocarcinoma in 2010–12 that received resectional surgery by age, sex, and disease stage

Colon tumours
Rectal tumours
Denmark England Norway Sweden Denmark England Norway Sweden
Age group, years
18–54 463 (70·2%) 4233 (74·3%) 495 (75·5%) 712 (82·5%) 371 (77·1%) 2065 (66·4%) 248 (71·7%) 465 (74·3%)
55–64 1091 (73·7%) 8951 (75·7%) 990 (73·6%) 1442 (80·3%) 705 (75·4%) 4083 (68·8%) 499 (73·5%) 860 (78·0%)
65–74 2077 (73·1%) 15 541 (76·2%) 1844 (75·5%) 2999 (82·1%) 1072 (71·4%) 5733 (68·6%) 664 (70·2%) 1439 (75·7%)
75–84 1818 (70·8%) 14 834 (67·6%) 1974 (73·9%) 3255 (83·3%) 698 (63·1%) 3962 (54·4%) 510 (63·0%) 1090 (69·0%)
85–99 591 (58·0%) 4244 (42·4%) 720 (58·7%) 1174 (74·9%) 136 (37·2%) 701 (24·1%) 143 (43·2%) 252 (42·8%)
Sex
Men 2917 (70·1%) 25 649 (68·8%) 2925 (71·6%) 4711 (80·2%) 1843 (69·0%) 10 820 (61·1%) 1239 (67·5%) 2427 (70·9%)
Women 3123 (70·9%) 22 154 (68·0%) 3098 (72·9%) 4871 (82·4%) 1139 (66·2%) 5724 (57·8%) 825 (64·7%) 1679 (70·7%)
Disease stage at diagnosis
Stage I 752 (89·6%) 6916 (93·3%) 836 (86·0%) 1328 (90·8%) 741 (93·4%) 5100 (89·9%) 605 (85·8%) 1122 (90·0%)
Stage II 2528 (92·8%) 16 438 (93·8%) 2189 (88·2%) 3541 (97·1%) 928 (89·9%) 3958 (78·9%) 556 (84·4%) 1145 (90·6%)
Stage III 1849 (90·8%) 15 555 (90·1%) 1688 (87·4%) 3282 (95·5%) 900 (84·7%) 5289 (70·3%) 539 (83·6%) 1361 (87·7%)
Stage IV 882 (39·1%) 6263 (39·9%) 1158 (55·6%) 1356 (50·8%) 307 (32·8%) 1293 (25·7%) 331 (47·4%) 376 (29·1%)
Unknown stage 29 (4·1%) 2631 (21·9%) 152 (17·4%) 75 (13·2%) 106 (18·6%) 904 (20·7%) 33 (8·2%) 102 (23·1%)
Total 6040 (70·5%) 47 803 (68·4%) 6023 (72·2%) 9582 (81·3%) 2982 (67·9%) 16 544 (59·9%) 2064 (66·3%) 4106 (70·8%)

Data are n (%). Resectional surgery defined as surgery to remove the primary tumour within 9 months of diagnosis, excluding diagnostic and palliative procedures.